Concepedia

Author

Paola Squarcina

Fondazione IRCCS Istituto Nazionale dei TumoriORCID

Also Known As

P Squarcina, P. Squarcina, Paola Squarcina

96

Publications

2.5K

Citations

17

H-Index

20

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei TumoriTumori FoundationIstituto Superiore di SanitàNational Institutes of HealthSapienza University of Rome
PS

About

Paola Squarcina is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in immunology, medicine, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

909

2

Immunology

6

6

909

3

Cell Biology

5

5

397

4

Pathology

2

2

268

5

Autoimmune Disease

1

1

87

Paola Squarcina

×

19

Publications

2.5K

Citations

17

H-Index

YearCitations

Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles

Giovanna Andreola, Licia Rivoltini, Chiara Castelli,

The Journal of Experimental Medicine

2002

745

Human Colorectal Cancer Cells Induce T-Cell Death Through Release of Proapoptotic Microvesicles: Role in Immune Escape

Veronica Huber, Stefano Fais, Manuela Iero,

Gastroenterology

2005

512

TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site

Licia Rivoltini, Claudia Chiodoni, Paola Squarcina,

Clinical Cancer Research

2016

182

Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35).

Douglas J. Loftus, Chiara Castelli, Timothy M. Clay,

The Journal of Experimental Medicine

1996

181

Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors

Cristina Federici, Eriomina Shahaj, Serena Cecchetti,

Frontiers in Immunology

2020

149

Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells

Licia Rivoltini, Chiara Castelli, Matteo Giovanni Carrabba,

The Journal of Immunology

2003

120

Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma.

Andrea Anichini, Roberta Mortarini, Cristina Maccalli,

PubMed

1996

87

Human Melanoma-Reactive CD4+ and CD8+ CTL Clones Resist Fas Ligand-Induced Apoptosis and Use Fas/Fas Ligand-Independent Mechanisms for Tumor Killing

Licia Rivoltini, Marina Radrizzani, Paola Accornero,

The Journal of Immunology

1998

82

Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35).

Douglas J. Loftus, Paola Squarcina, Mai Britt Nielsen,

PubMed

1998

70

Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I–Modified Peptides

Paola Filipazzi, Lorenzo Pilla, Luigi Mariani,

Clinical Cancer Research

2012

70

Page 1